---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-010872"
form_type: "8-K"
ticker: "AHCO"
cik: "0001725255"
company_name: "AdaptHealth Corp."
filed_at: "2026-02-24T23:59:59+00:00"
generated_at: "2026-05-16T00:50:50.679950+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AdaptHealth reports Q4 net loss $102.8M, FY net loss $70.8M; guides FY2026 rev up to $3.51B, EBITDA $680-730M

## Summary
- Full-year 2025 net loss $70.8M vs net income $90.4M in 2024; includes $128M goodwill impairment.
- Q4 2025 net revenue $846.3M (-1.2% YoY); Adjusted EBITDA $163.1M (-18.7%).
- FY 2025 Adjusted EBITDA $616.7M (-10.5%); free cash flow $219.4M.
- 2026 guidance: Net revenue $3.44B-$3.51B, Adjusted EBITDA $680M-$730M, free cash flow $175M-$225M.
- Debt reduced $250M in FY 2025; credit upgrades from S&P and Moody's; patient census records set.

## SEC filing metadata
- accession: 0001628280-26-010872
- form_type: 8-K
- ticker: AHCO
- cik: 0001725255
- company_name: AdaptHealth Corp.
- filed_at: 2026-02-24T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725255/000162828026010872/0001628280-26-010872-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725255/000162828026010872/ahco-20260224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-010872
- JSON: https://secwatch.observer/filing/0001628280-26-010872.json
- Plain text: https://secwatch.observer/filing/0001628280-26-010872.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.